Market capitalization | $74.14b |
Enterprise Value | $142.98b |
PER (TTM) P/E ratio | 10.38 |
EV/FCF (TTM) EV/FCF | 17.57 |
EV/Sales (TTM) EV/Sales | 0.40 |
P/S ratio (TTM) P/S ratio | 0.21 |
P/B ratio (TTM) P/B ratio | 1.00 |
Dividend yield | 4.10% |
Last dividend (FY23) | $2.42 |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
29 Analysts have issued a CVS Health forecast:
29 Analysts have issued a CVS Health forecast:
Mar '24 |
+/-
%
|
||
Turnover | 361,345 361,345 |
9%
9%
|
|
Gross income | 54,027 54,027 |
1%
1%
|
|
EBITDA | 18,592 18,592 |
9%
9%
|
EBIT (operating result) EBIT | 14,089 14,089 |
13%
13%
|
Net profit | 7,321 7,321 |
84%
84%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Head office | United States |
CEO | Karen Lynch |
Employees | 300,000 |
Founded | 1963 |
Website | www.cvshealth.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.